Research Article
Impact of the Glycemic Control and Duration of Type 2 Diabetes on Vitamin D Level and Cardiovascular Disease Risk
Table 7
Correlation of 25-hydroxyvitamin D level with cardiovascular risk scores among different studied groups.
| | Normal | Newly diagnosed controlled | Newly diagnosed uncontrolled | Long-lasting controlled | Long-lasting uncontrolled |
| ASCVD risk 10 year | | | | | | | — | 0.018 | 0.304 | 0.229 | −0.109 | Sig | — | 0.940 | 0.337 | 0.306 | 0.603 | Hard CVD patient risk | | | | | | | −0.071 | −0.036 | 0.446 | −0.080 | −0.124 | Sig | 0.735 | 0.864 | 0.073 | 0.705 | 0.555 | Full CVD patient risk | | | | | | | −0.027 | 0.048 | 0.525 | −0.046 | −0.150 | Sig | 0.898 | 0.820 | 0.031 | 0.828 | 0.475 | Lifetime ASCVD risk | | | | | | | 0.074 | 0.220 | 0.012 | −0.023 | −0.453 | Sig. | 0.727 | 0.290 | 0.964 | 0.915 | 0.023 | Fasting blood glucose level | | | | | | | 0.102 | 0.002 | 0.132 | −0.111 | 0.032 | Sig. | 0.626 | 0.992 | 0.614 | 0.596 | 0.879 |
|
|